Michael Kolodziej, MD

Michael Kolodziej, MD, is vice president and chief innovation officer at ADVI Health, which he joined in 2017. He is a Fellow of the American College of Physicians. He has published and spoken extensively on payment reform, personalized medicine, and practice care delivery transformation in oncology. Prior to ADVI Health, Dr. Kolodziej served as Flatiron Health’s National Medical Director, Managed Care Strategy, where he applied the core tech and data capabilities of Flatiron to facilitate practice transformation and success in alternative payment models. Before Flatiron, Dr. Kolodziej worked at Aetna as National Medical Director, Oncology Solutions, where he directed Aetna’s oncology delivery reform pilots and was the architect of the Aetna Oncology Medical Home program. He was also active in Aetna’s pharmacy policy, condition analysis, and genetics subcommittees. He served as Medical Director for Oncology Services for U.S. Oncology from 2007 to 2011. In this role, he helped direct the implementation of the USON clinical pathways initiative, the integration of the USON EMR into this program, and the development of the USON disease management and advanced care planning programs, now known as Innovent Oncology. Prior to this role, Dr. Kolodziej served as a partner of New York Oncology from 1998 until 2012. During this time, he was an active member of the US Oncology Pharmacy and Therapeutics committee, on the executive committee from 2002-2011, and chairman from 2004-2011. Directly after his medical training, Dr. Kolodziej was an associate professor at the University of Oklahoma School of Medicine. He attended college and medical school at Washington University in St. Louis, where he was Phi Beta Kappa and Alpha Omega Alpha. He completed internal medicine and hematology-oncology training at the University of Pennsylvania in Philadelphia.